Exact Mass: 378.0108842
Exact Mass Matches: 378.0108842
Found 98 metabolites which its exact mass value is equals to given mass value 378.0108842
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Chlorflavonin
A dihydroxyflavone that is flavone substituted by a chloro group at position 3, hydroxy groups at positions 5 and 2 and methoxy groups at positions 3, 7 band 8 respectively.
6-Methylthiopurine 5'-monophosphate ribonucleotide
C11H15N4O7PS (378.03990500000003)
6-Methylthiopurine 5-monophosphate ribonucleotide, also known as methylthioinosine-5-monophosphate or meTIMP, is a metabolite of mercaptopurine. Mercaptopurine (also called 6-mercaptopurine, 6-MP, or its brand name Purinethol) is an immunosuppressive drug. Mercaptopurine is in the thiopurine and antimetabolite family of medications (Wikipedia). MeTIMP produced from 6-thioinosine monophosphate (6-TIMP) by thiopurine methyltransferase (TPMT) is an active metabolite that can inhibit de novo purine biosynthesis. High concentration of meTIMP has been related to hepatotoxicity and myelotoxicity (PMID: 21311411).
3,4,5-trihydroxy-6-({7-oxo-7H-furo[3,2-g]chromen-4-yl}oxy)oxane-2-carboxylic acid
C17H14O10 (378.05869440000004)
3,4,5-trihydroxy-6-({7-oxo-7h-furo[3,2-g]chromen-4-yl}oxy)oxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 4-hydroxy-7h-furo[3,2-g]chromen-7-one. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.
6-Methylthiopurine ribonucleoside
C11H15N4O7PS (378.03990500000003)
Edta oxalate
Pentafluorobenzyl ether
1-[[Difluoro-(2,3,4-trifluorophenyl)methoxy]-difluoromethyl]-2,3,4-trifluorobenzene
Casoxin D
Isolated from the proteolytic digest of human milk casein
(2R,5aS,7S,9aS)-7-Bromo-2-(bromomethyl)-2,5,5a,6,7,8,9,9a-octahydro-3,6,6,9a-tetramethyl-1-benzoxepin
C15H24Br2O (378.01937739999994)
(8R*)-8-Bromo-10-epi-beta-Snyderol
C15H24Br2O (378.01937739999994)
2-Bromo-4-(4-bromo-3,3-dimethylcyclohexyl)-1-methyl-7-oxabicyclo[2.2.1]heptane
C15H24Br2O (378.01937739999994)
Methyl 3-[2-(dicyanomethylidene)hydrazino]-4-[(2-furylmethyl)sulfonyl]thiophene-2-carboxylate
3-(2-chloro-6-fluorophenyl)-N-(5-cyclopropyl-1,3,4-thiadiazol-2-yl)-5-methyl-1,2-oxazole-4-carboxamide
2-(4-Chlorobenzoyl)-3-{[1-(4-chlorophenyl)-1-methyl-1-oxo-λ6-sulfanylidene]amino}acrylonitrile
62FTA
Disclaimer: While authors make an effort to ensure that the content of this record is accurate, the authors make no representations or warranties in relation to the accuracy or completeness of the record. This record do not reflect any viewpoints of the affiliation and organization to which the authors belong.
2,2,3-Trifluoro-3-(1,1,2,2,3,3-hexafluoro-3-(trifluoromethoxy)propoxy)propanoic acid
(2S*,6R*,8R*,9R*)-2,8-dibromo-9-hydroxy-beta-chamigrene
C15H24Br2O (378.01937739999994)
(Z,E)-14,14-dibromotetradec-4,6,13-trienoic acid
C14H20Br2O2 (377.98299399999996)
5-Chlor-dermorubin|6,8-Di-Me ether,5-chloro-1,4,6,8-Tetrahydroxy-3-methyl-2-anthraquinonecarboxylic acid
Adona
CONFIDENCE standard compound; INTERNAL_ID 5932; The reference standard is the sodium salt of ADONA: C7H1F12O4Na: Its ionic formula is [M-Na]-
ETHYL 2-(2-CHLORO-6-IODOQUINAZOLIN-3(4H)-YL)ACETATE
C12H12ClIN2O2 (377.96320319999995)
Polyethylene glycol, disulfobutyl ether, disodium salt
Copper(I) hexafluoro-2,4-pentanedionate-1,5-cyclooctadiene complex
(2R)-7β-Bromo-2-(bromomethyl)-2,5,5aα,6,7,8,9,9a-octahydro-3,6,6,9aβ-tetramethyl-1-benzoxepin
C15H24Br2O (378.01937739999994)
5-CHLORO-3-IODO-PYRROLO[2,3-B]PYRIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
C12H12ClIN2O2 (377.96320319999995)
Methyl 2-[5-[2-(2,4-Dichlorophenoxy)phenyl]-2H-tetrazol-2-yl]acetate
C16H12Cl2N4O3 (378.02864220000004)
N-(4-CHLORO-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-2-YL)-2,2-DIMETHYLPROPIONAMIDE
C11H12ClIN4O (377.97443619999996)
(4-methoxyphenyl) 4-phenyl-5-(trifluoromethyl)thiophene-2-carboxylate
1-Piperazineethanol, 4-[(5-bromo-2-methoxyphenyl)sulfonyl]
4-IODO-N,N-DIMETHYL-3-(PYRIDIN-2-YL)-1H-PYRAZOLE-1-SULFONAMIDE
3,5-bis-(Chloromethyl)octamethyltetrasiloxane
C10H28Cl2O3Si4 (378.04925180000004)
1-(2,6-Dichlorophenyl)-2-indolinone
C18H16Cl2N2O3 (378.05379259999995)
5-[(3-ethylbenzothiazol-2(3H)-ylidene)ethylidene]-4-oxo-2-thioxothiazolidin-3-acetic acid
C16H14N2O3S3 (378.01665340000005)
N-[[(5S)-3-(3-fluoro-4-iodophenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide
C12H12FIN2O3 (377.98766839999996)
ETHANONE, 1-[6-BROMO-1-(PHENYLSULFONYL)-1H-PYRROLO[2,3-B]PYRIDIN-3-YL]-
2-Methyl-2-propanyl 4-chloro-3-iodo-1H-pyrrolo[2,3-b]pyridine-1-c arboxylate
C12H12ClIN2O2 (377.96320319999995)
2,5-dibromo-4-((2-ethylhexyl)oxy)phenol
C14H20Br2O2 (377.98299399999996)
5-ethyl-N-[2-(2-phenyl-4-thiazolyl)ethyl]-2-thiophenesulfonamide
C17H18N2O2S3 (378.05303680000003)
(5-Bromo-2-furanyl)-[2-[(3-methylphenyl)methylthio]-4,5-dihydroimidazol-1-yl]methanone
2-Bromo-2-(((4-methylphenyl)sulfonyl)methyl)-1-indanone
3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluorooctanoic acid
[(2R,3S,4R,5R)-3,4-dihydroxy-5-(2,6,8-trioxo-3,7-dihydropurin-9-yl)oxolan-2-yl]methyl phosphate
4-(3-Bromophenyl)-7-methyl-2-(4-methylphenyl)pyrazolo[3,4-d]pyridazine
2-(1,3-benzothiazol-2-ylthio)-N-(4-methylphenyl)sulfonylacetamide
C16H14N2O3S3 (378.01665340000005)
N-[[[(2-chlorophenyl)-oxomethyl]hydrazo]-sulfanylidenemethyl]-2-nitrobenzamide
C15H11ClN4O4S (378.01895160000004)
N-[5-[methyl-(3-methylphenyl)sulfamoyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide
5-Amino-4-cyano-3-methyl-thiophene-2-carboxylic acid (3-bromo-4-hydroxy-benzylidene)-hydrazide
6-bromo-N-(2-methylphenyl)-2-pyridin-4-yl-3-imidazo[1,2-a]pyridinamine
6-[2-(5-Chloro-2-methoxyanilino)-2-oxoethyl]-5-thieno[2,3-b]pyrrolecarboxylic acid methyl ester
C17H15ClN2O4S (378.04410200000007)
N-(4-bromo-2-fluorophenyl)-1-methylsulfonyl-4-piperidinecarboxamide
7-[(6,8-Dichloro-4-quinazolinyl)oxymethyl]-5-thiazolo[3,2-a]pyrimidinone
N-[5-[ethyl(phenyl)sulfamoyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide
2-(Benzenesulfonamido)acetic acid [2-(4-nitrophenyl)-2-oxoethyl] ester
4,5-Dichloro-3-isothiazolecarboxylic acid [1-oxo-1-(thiophen-2-ylmethylamino)butan-2-yl] ester
N-[(E)-[5-chloro-1-(3-chlorophenyl)-3-methylpyrazol-4-yl]methylideneamino]thiophene-2-carboxamide
5,7-Dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl sulfate
5-bromo-N-(6-butyl-1,3-benzothiazol-2-yl)-2-furancarboxamide
3-[2-(2-Naphthalenylsulfonyl)-1-oxoethyl]-1-benzopyran-2-one
C21H14O5S (378.05619140000005)
(3R)-3-(2-chloro-1,3-thiazol-5-yl)-5-hydroxy-8-methyl-6-phenyl-2,3-dihydro-[1,3]thiazolo[3,2-a]pyrimidin-4-ium-7-one
2-(Perfluoropentyl)ethane-1-sulfonic acid
C7H5F11O3S (377.9783752000001)
tetracenomycin D3(2-)
A hydroxy monocarboxylic acid anion obtained by deprotonation of the carboxy and 8-hydroxy groups of tetracenomycin D3. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
6-Methylthioinosine-5-monophosphate
C11H15N4O7PS (378.03990500000003)
3,4,5-trihydroxy-6-({7-oxo-7H-furo[3,2-g]chromen-4-yl}oxy)oxane-2-carboxylic acid
C17H14O10 (378.05869440000004)
5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl sulfate(1-)
An aryl sulfate oxoanion that is the conjugate base of 5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl hydrogen sulfate, obtained by deprotonation of the sulfo group; major species at pH 7.3.
2-{3,5-dibromo-4-[3-(dimethylamino)propoxy]phenyl}ethanamine
C13H20Br2N2O (377.99422699999997)
5-[(1r,3r)-3,5-dibromo-2,2-dimethyl-6-methylidenecyclohexyl]-3-methylpent-1-en-3-ol
C15H24Br2O (378.01937739999994)
(3s)-5-[(1s,3s,5s)-3,5-dibromo-2,2-dimethyl-6-methylidenecyclohexyl]-3-methylpent-1-en-3-ol
C15H24Br2O (378.01937739999994)
(2r,3r,6r,8s)-2,8-dibromo-3,7,7-trimethyl-11-methylidenespiro[5.5]undecan-3-ol
C15H24Br2O (378.01937739999994)
(3r)-5-[(1r,3r,5r)-3,5-dibromo-2,2-dimethyl-6-methylidenecyclohexyl]-3-methylpent-1-en-3-ol
C15H24Br2O (378.01937739999994)